Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Oncological benefit of re-resection for T1 bladder cancer: a comparative effectiveness study
BJU International ( IF 3.7 ) Pub Date : 2021-10-21 , DOI: 10.1111/bju.15622 Marian S Wettstein 1, 2, 3, 4 , Nancy N Baxter 2, 3 , Rinku Sutradhar 2, 3 , Muhammad Mamdani 2, 3 , Pham Song 3 , Syed R Qadri 1 , Kathy Li 1 , Ning Liu 3 , Theodorus van der Kwast 5 , Thomas Hermanns 4 , Girish S Kulkarni 1, 2, 3
BJU International ( IF 3.7 ) Pub Date : 2021-10-21 , DOI: 10.1111/bju.15622 Marian S Wettstein 1, 2, 3, 4 , Nancy N Baxter 2, 3 , Rinku Sutradhar 2, 3 , Muhammad Mamdani 2, 3 , Pham Song 3 , Syed R Qadri 1 , Kathy Li 1 , Ning Liu 3 , Theodorus van der Kwast 5 , Thomas Hermanns 4 , Girish S Kulkarni 1, 2, 3
Affiliation
To quantify the real-world survival benefit of re-resection vs no re-resection in patients diagnosed with T1 bladder cancer (BC) at the population level.
中文翻译：
再次切除 T1 期膀胱癌的肿瘤学益处：比较有效性研究
量化在人群水平上诊断为 T1 膀胱癌 (BC) 的患者，再切除术与未再切除术的真实世界生存获益。
更新日期：2021-10-21
中文翻译：
再次切除 T1 期膀胱癌的肿瘤学益处：比较有效性研究
量化在人群水平上诊断为 T1 膀胱癌 (BC) 的患者，再切除术与未再切除术的真实世界生存获益。
京公网安备 11010802027423号